title: Interleukin-1 receptor antagonist in animal models of stroke: a fair summing up?
authors.forename: Adrian
authors.initials: A
authors.lastname: Parry-Jones
authors.forename: Hervé
authors.initials: H
authors.lastname: Boutin
authors.forename: Adam
authors.initials: A
authors.lastname: Denes
authors.forename: Barry
authors.initials: B
authors.lastname: McColl
authors.forename: Steve
authors.initials: S
authors.lastname: Hopkins
authors.forename: Stuart
authors.initials: S
authors.lastname: Allan
authors.forename: Pippa
authors.initials: P
authors.lastname: Tyrrell
mesh_terms: D000818:Animals; D002545:Brain Ischemia / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D004195:Disease Models, Animal; D019317:Evidence-Based Medicine; D053590:Interleukin 1 Receptor Antagonist Protein / Q000494:pharmacology*; D015201:Meta-Analysis as Topic; D015203:Reproducibility of Results; D012196:Review Literature as Topic; D020521:Stroke / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
chemical_list: D053590:Interleukin 1 Receptor Antagonist Protein